Examining the Least Invasive Diagnostic Procedures in Wilson Disease and AATD
Researchers compare the least invasive diagnostic tests for Wilson disease and alpha-1 antitrypsin deficiency.
Researchers compare the least invasive diagnostic tests for Wilson disease and alpha-1 antitrypsin deficiency.
Lung volume reduction has been shown to provide symptomatic relief to patients with end-stage chronic obstructive pulmonary disease.
A combination of targeted screening programs and smoking cessation initiatives can turn the tide against severe AATD.
Studies reveal that manifestations of lung disease in AATD are associated with symptoms of depression and/or anxiety.
Active surveillance of important health parameters in AATD is important to ensure that quality of life is preserved as much as possible.
Liver organoids have been used to regenerate hepatocellular parenchyma and bile ducts, providing a convenient platform for research and clinical purposes.
It is challenging for physicians to diagnose AATD in a patient with an existing asthma diagnosis since so many symptoms overlap.
Patients with alpha-1 antitrypsin deficiency, along with their caregivers, struggle with a significant and multifaceted disease burden.
Self-infusion is an option for patients with alpha-1 antitrypsin deficiency, meaning that the bulk of treatment can now take place at home.
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.